APA (7th ed.) Citation

Zakaria, Z., Tivnan, A., Flanagan, L., Murray, D. W., Salvucci, M., Stringer, B. W., . . . Prehn, J. H. M. (2016). Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant. British Journal of Cancer, 114(2), 188. https://doi.org/10.1038/bjc.2015.420

Chicago Style (17th ed.) Citation

Zakaria, Z., et al. "Patient-derived Glioblastoma Cells Show Significant Heterogeneity in Treatment Responses to the Inhibitor-of-apoptosis-protein Antagonist Birinapant." British Journal of Cancer 114, no. 2 (2016): 188. https://doi.org/10.1038/bjc.2015.420.

MLA (9th ed.) Citation

Zakaria, Z., et al. "Patient-derived Glioblastoma Cells Show Significant Heterogeneity in Treatment Responses to the Inhibitor-of-apoptosis-protein Antagonist Birinapant." British Journal of Cancer, vol. 114, no. 2, 2016, p. 188, https://doi.org/10.1038/bjc.2015.420.